greeksoup/ stock research

Astera Labs (ALAB) Q4 FY2023 earnings: revenue $51 million

Astera Labs, Inc. (ALAB) reported revenue of $51 million for Q4 FY2023, the quarter ended 31 December 2023. Net income was $14 million. The figures are the company's own, from the 10-K it filed with the SEC on 14 February 2025.

Revenue$51 million
Net income$14 million
Diluted EPSn/a
QuarterQ4 FY2023ended 31 December 2023

The quarter, against the one before and a year earlier

LineQ4 FY2023Q3 FY2023A year earlierChange on the year
Revenue50.536.9n/an/a
Cost of revenue11.58.8n/an/a
Gross profit39.028.1n/an/a
Gross margin77.3%76.1%n/a
Research and development19.720.6n/an/a
Operating income9.0-2.0n/an/a
Operating margin17.9%-5.4%n/a
Pre-tax income10.7-0.3n/an/a
Income tax-3.62.9n/an/a
Effective tax rate-34.0%n/an/a
Net income14.3-3.1n/an/a
Net margin28.4%-8.5%n/a
Diluted EPSn/a-$0.08n/an/a
$ million except per share.
Read moreFourth quarters are the year less the first three quarters. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow and capital returned

LineQ4 FY2023Q3 FY2023A year earlierChange on the year
Operating cash flow14.4-0.3n/an/a
Capital expenditure1.00.7n/an/a
Free cash flow13.4-1.1n/an/a
Free cash flow margin26.5%-2.9%n/a
Cash from investing-6.0-56.3n/an/a
Cash from financing-1.10.6n/an/a
Share-based compensation3.32.7n/an/a
Diluted shares, weighted37m37mn/an/a
Shares outstanding at period end42m159mn/an/a

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet at quarter end

LineQ4 FY2023Q3 FY2023A year earlierChange on the year
Shareholders' equity-97.7-117n/an/a
Redeemable equity255n/an/an/a
Debt0.0n/an/an/a
Operating lease liabilities0.8n/an/an/a
Other liabilities38.1n/an/an/a
Total liabilities and equity196n/an/an/a
Fixed assets4.7n/an/an/a
Investments104n/an/an/a
Cash and equivalents45.137.7n/an/a
Receivables8.3n/an/an/a
Inventory24.1n/an/an/a
Other assets9.8n/an/an/a
Total assets196n/an/an/a

Questions

What was Astera Labs' revenue in Q4 FY2023?

Astera Labs (ALAB) reported revenue of $51 million for Q4 FY2023, the quarter ended 31 December 2023.

How much did Astera Labs earn in Q4 FY2023?

Net income for Q4 FY2023 was $14 million.

When did Astera Labs report Q4 FY2023 results?

Astera Labs filed its 10-K for the year that ended with the quarter on 14 February 2025; the fourth quarter is the year less the first three.

Quarterly results, the last 14 quarters

Q1 FY2023Q2 FY2023Q3 FY2023Q4 FY2023 *Q1 FY2024 †Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025 †Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026
Revenue17.710.736.950.565.376.8113141159192231271308392
Cost of revenue13.42.28.811.514.717.025.236.640.046.454.866.173.2105
Gross profit4.38.428.139.050.559.987.9104119146176204235288
Gross margin24%79%76%77%77%78%78%74%75%76%76%76%76%73%
R&D15.317.920.619.753.640.150.756.564.666.778.993.8126136
Operating income-18.9-17.6-2.09.0-83.0-24.3-8.90.111.339.855.467.061.889.2
Operating margin-107%-165%-5%18%-127%-32%-8%0%7%21%24%25%20%23%
Pre-tax income-17.3-16.1-0.310.7-80.4-14.12.010.721.750.766.978.973.4103
Tax raten/an/an/a-34%n/an/a477%-131%-47%-1%-36%43%-9%-49%
Net income-17.5-20.0-3.114.3-93.0-7.5-7.624.731.851.291.145.080.3153
Net margin-99%-187%-8%28%-143%-10%-7%18%20%27%40%17%26%39%
Diluted EPS-$0.49-$0.55-$0.08n/a-$1.77-$0.05-$0.05$0.14$0.18$0.29$0.50$0.25$0.44$0.83
Operating cash flow-3.8-23.0-0.314.43.729.863.539.710.513578.295.374.687.7
Capital expenditure0.40.60.71.03.4n/a16.715.44.52.012.318.77.620.5
Free cash flow-4.3-23.5-1.113.40.2n/a46.824.36.013365.976.667.067.2
Shares outstanding156m157m159m42m155m157m159m162m165m166m169m170m171m173m
Filing10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. A blank figure marked on a quarter is one the filings do not give on their own: the quarters as filed do not add to the year the company filed, or the year and its quarters stand on different share counts. Each quarter's page says which. A quarter marked † is shown as the company last restated it in a later filing, so it compares with the quarters around it on one basis; rest on a figure for the one first filed. EPS is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

10-K for the period ended 31 December 2023, filed 14 February 2025: the filing.